Newsletter Signup | Join Community
62
4
Overview of the Ewing’s Sarcoma Family of Tumors
Votrient Approved for the Treatment of Sarcoma
Yondelis® Bests Standard Therapy in Liposarcoma and Leiomyosarcoma
Novel Approach to Prime Immune System Seeks to Prevent Spread of Soft-Tissue Cancer
Halaven Promising in Soft-Tissue Sarcoma
New Combination Promising for Ewing Sarcoma
Yondelis® Approved for Treatment of Soft Tissue Sarcoma
Halaven® (eribulin) may extend overall survival in patients with previously treated, advanced soft tissue sarcoma (STS).
YONDELIS® (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma
Survival for Soft Tissue Sarcoma Patients Improved at High-volume Centers
Torisel Improves Event-Free Survival in Rhabdomyosarcoma Patients
Radiation Therapy Is Beneficial after Surgery and Chemotherapy in Children with Rhabdomyosarcoma,
Shorter Chemotherapy Intervals Effective in Ewing Sarcoma
Genetic Change Linked with Rhabdomyosarcoma Survival
Carbon Ion Beam Radiation Effective in Spinal Sarcomas
Isolated Limb Perfusion with TNF and Alkeran® Spares Limbs in Soft-Tissue Sarcomas
Patients with Hereditary Retinoblastoma Have Increased Risk of Soft-tissue Sarcomas
Surgery for Osteosarcoma Increases Cure Rates over Chemotherapy Alone
Gemzar® Plus Taxotere® Active in Recurrent Sarcoma
Dose-intensive Epirubicin and Ifosfamide Followed By Surgery is an Effective for the Treatment of Adults with Sarcomas
Children with Sarcoma at Higher Risk for Blood Clots
PET Useful for Initial Evaluation of Children with Rhabdomyosarcoma
PET Scan More Accurate Predictor of Treatment Response for Soft Tissue Sarcomas
Nexavar Improves Survival for Patients with Rare Sarcomas.
Percutaneous Core Needle Biopsy Recommended for Diagnosis of Sarcomas
Evaluation of anlotinib in sarcoma appears promising and confirmatory trials and ongoing in the United States.
Differences in IMRT Radiation Doses May Complicate Study Results in Sarcomas
Taxotere® plus Gemzar® Provides Anticancer Responses in Metastatic Soft-Tissue Sarcomas
Early phases of clinical trials evaluating a new compound called
Addition of Avastin® to Chemotherapy May Slow Disease Progression in Metastatic Soft-Tissue Sarcoma
Paclitaxel Shows Activity against Angiosarcoma of the Scalp and Face
Combination of Irinotecan and Vincristine Active Against Metastatic Rhabdomyosarcoma
Surgery for Recurrent Rhabdomyosarcoma May Improve Survival
Gleevec® Produces a Treatment Response in Some Patients with Desmoid Tumors
New Combination Therapy for Soft-Tissue Sarcoma of the Arm or Leg May Spare Limb
Camptosar® Evaluated in Children with Relapsed or Refractory Rhabdomyosarcoma
Stem Cell Transplantation Improves Survival for Select Patients with Soft-Tissue Sarcoma
Chromosomal Changes Linked with Prognosis in Adult Soft Tissue Sarcoma
Thalidomide Produces Responses in Persons with AIDS-Related Kaposi’s Sarcoma
Researchers Evaluate Treatment Outcomes for Children with Non-Rhabdomyosarcoma Soft-Tissue Sarcomas
Additional Chemotherapy to Standard Regimen Improves Survival in Ewing’s Sarcoma
High-risk Soft Tissue Sarcoma Patients Benefit from Targeted Heat Therapy Combined with Chemotherapy
Targeted Heat Therapy Improves Outcomes for Soft Tissue Sarcoma
Long-Term Follow-Up Care Needed for Osteosarcoma Patients
Determining Risk for Relapse Allows Less Radiation Therapy for Some Children with Soft-Tissue Sarcoma
Molecular Markers Detect Cancer Spread in Rhabdomyosarcoma
Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Sarcomas.
Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence
Sirolimus Effectively Halts Kaposi’s Sarcoma in Renal Transplant Patients
Gleevec® Promising for AIDS-Related Kaposi’s Sarcoma
High-Dose Therapy May Improve Outcome for Patients with Relapsed Ewing’s Sarcoma
Curious if others have experience with Lartruvo working and are nervous about the new study results?…
Is Adavosertib ready for sarcoma clinical trials? …
New immunotherapy trial for advanced sarcoma: Researchers at the University of Texas MD Anderson…
Specialized sarcoma treatment programs should be considered by all sarcoma patients. These uncommon…